Quick Heal Technologies Ltd. · NSE:QUICKHEAL

Quick Heal Technologies — Q1 FY18 Earnings Presentation

22 slides from Quick Heal Technologies's earnings presentation, August 2017

  1. Slide 1: Quick Heal Technologies Limited Q1 FY18 – Results Update

    Quick Heal Technologies Limited Q1 FY18 – Results Update August 2017 1

  2. Slide 2: Disclaimer

    DISCLAIMER This presentation and the following discussion may contain “forward looking statements” by Quick Heal Technologies Limited (“Quick Heal” or the “Company”) that are not historical in nature. These forward looking statements, which may include statements relating to future results of operat

  3. Slide 3: Discussion Summary

    DISCUSSION SUMMARY • COMPANY OVERVIEW • STRATEGY & OUTLOOK • Q1 FY18 RESULT ANALYSIS • Q1 FY18 FINANCIALS • SHAREHOLDING STRUCTURE 3

  4. Slide 4: Company Overview: Quick Heal Journey

    COMPANY OVERVIEW QUICK HEAL JOURNEY • Listing on BSE and NSE exchanges • ISO 27001, ISO 20000 • Launches ‘Seqrite Services’ and ‘Quick Heal Academy’ • Crosses 1 million active licenses in • Launches Seqrite a brand for Business Enterprise Security segment Enterprises • SEQRITE listed as Top Product

  5. Slide 5: Strong Brand Recognition and Recall

    COMPANY OVERVIEW STRONG BRAND RECOGNITION AND RECALL 8.02 m 1.8x Growth 30% + Preferred Choice of IT technicians for PC Active Licenses across more Active Licenses over last Retail Market Share in India Virus Cleaning than 80 countries 5 years 16,712 Retail, 349 Enterprise and 98 Government Partners

  6. Slide 6: Technology & Market Leadership

    COMPANY OVERVIEW TECHNOLOGY & MARKET LEADERSHIP International Certificates Awards in India • 2017: Quick Heal Total Security receives BEST +++ certification from AV Lab. • 2017: SEQRITE listed as Top Products in the prestigious AV-TEST certification and BEST +++ from AV Lab • 2017: Quick Heal Total

  7. Slide 7: Large and Growing User Base: Annual Growth

    COMPANY OVERVIEW LARGE AND GROWING USER BASE ACTIVE LICENSES (‘000) – ANNUAL GROWTH TREND 7,847 7,323 6,317 5,450 4,386 MAR-13 MAR-14 MAR-15 MAR-16 MAR-17 7

  8. Slide 8: Large and Growing User Base: Quarterly Growth

    COMPANY OVERVIEW LARGE AND GROWING USER BASE ACTIVE LICENSES (‘000) – QUARTERLY GROWTH TREND 8,024 7,847 7,642 7,496 SEP-16 DEC-16 MAR-17 JUN-17 8

  9. Slide 9: Extensive Reach & Presence

    COMPANY OVERVIEW EXTENSIVE REACH & PRESENCE Quick Heal – 63 offices & warehouses across 35 cities in India INDIA (HO) UAE DUBAI Quick Heal Technologies Quick Heal Technologies Seqrite Technologies Head Office & R&D Center Ltd. (MENA) FZE DMCC Pune USA JAPAN KENYA Quick Heal Technologies Quick Heal T

  10. Slide 10: Strategy and Outlook

    STRATEGY AND OUTLOOK • Work ongoing on several new technologies such as • Product Innovation to IoT and home secure mobile for • Focus on international security automation digital transactions expansion through • Has 4 US patents to • Monetize opportunities consistent brand its credit. Awaiting 3 of

  11. Slide 11: Key Highlights – Recent Cyber Attacks

    KEY HIGHLIGHTS – RECENT CYBER ATTACKS ‘FIREBALL’ BANKS IN INDIA LOST RS 2,520 MN DUE TO CYBER ATTACKS OVER LAST 3 YEARS Chinese Malware affected 250 mn personal computers • According to RBI study, Banks lost Rs 88,553 per globally in May 2017 and India faced the worst impact with hour on an average

  12. Slide 12: Q1 FY18 Results Highlights

    Q1 FY18 RESULTS HIGHLIGHTS In Rs. Million REVENUES EBITDA and EBITDA MARGIN 475.5 '(33.9) -7.1% 303.2 '(160.6) -53.0% Q1 FY17 Q1 FY18 Q1 FY17 Q1 FY18 EBIDTA EBIDTA Margin % PAT and PAT MARGIN CASH PROFIT # 19.3 '(54.7) -11.5% '(113.1) -37.3% '(48.8) Q1 FY17 Q1 FY18 Q1 FY17 Q1 FY18 PAT PAT Margin % *

  13. Slide 13: Q1 FY18 – Revenue Analysis

    Q1 FY18 – REVENUE ANALYSIS In Rs. Million SEGMENT BREAKUP * NUMBER OF LICENSES SOLD (‘000) 512.2 997.4 139.2 233.1 313.5 502.2 144.6 373.0 764.3 275.2 168.8 227.0 Q1 FY17 Q1 FY18 Q1 FY17 Q1 FY18 % Share Q1 FY17 Q1 FY18 % Share Q1 FY17 Q1 FY18 Retail 72.8% 53.9% Retail 76.6% 45.2% Enterprises & Gover

  14. Slide 14: Q1 FY18 – Cost Analysis

    Q1 FY18 – COST ANALYSIS Rs Million Consolidated Head Q1 FY18,a Q4 FY17,a Q3 FY17,a Q2 FY17,a Q1 FY17, a Operating Cost Salaries 116.8 116.5 118.7 122.4 120.8 Fees for technical services 24.1 24.9 24.9 25.2 25.1 Technology subscription charges 3.5 14.2 13.6 16.2 12.8 R&D Expenses (A) 144.4 155.6 157.

  15. Slide 15: Consolidated Results – Profit & Loss

    Q1 FY18 CONSOLIDATED RESULTS – PROFIT & LOSS Rs Million Consolidated Head Q1 FY18,a Q1 FY17,a Growth % Change Revenue 303.2 475.5 -172.3 -36.2% Direct Cost 19.0 45.5 26.5 58.3% Gross profit 284.2 430.0 -145.8 -33.9% Gross Margin, % 93.7% 90.4% Operating Costs R&D Cost 144.4 158.8 14.4 9.1% Sales and

  16. Slide 16: Consolidated Results – Ratio Analysis

    Q1 FY18 CONSOLIDATED RESULTS – RATIO ANALYSIS Ratio Analysis Consolidated Head Q1 FY18,a Q1 FY17,a Expenses Direct Cost / Revenue 6.3% 9.6% R&D / Revenue 47.6% 33.4% S&M / Revenue 57.4% 35.3% G&A / Revenue 41.6% 28.9% Total Cost / Revenue 146.7% 97.6% Margin Gross Margin 93.7% 90.4% EBIDTA -53.0% -7

  17. Slide 17: Consolidated Results – Balance Sheet

    Q1 FY18 CONSOLIDATED RESULTS – BALANCE SHEET Rs Million Particulars Jun-17 Jun-16 Particulars Jun-17 Jun-16 Non-Current Assets: Share Holders’ Funds: Property, plant and equipment 1,763.3 1,750.0 Equity share capital 701.9 700.3 Capital work-in-progress 133.0 94.7 Share application money pending Oth

  18. Slide 18: Standalone Results – Profit & Loss

    Q1 FY18 STANDALONE RESULTS – PROFIT & LOSS Rs Million Standalone Head Q1 FY18, a Q1 FY17, a Growth % Change Revenue 297.2 475.1 -177.9 -37.4% Direct Cost 18.9 42.9 24.0 56.0% Gross profit 278.4 432.2 -153.9 -35.6% Gross Margin, % 93.7% 91.0% Operating Costs R&D Cost 144.4 158.8 14.4 9.1% Sales and M

  19. Slide 19: Standalone Results – Ratio Analysis

    Q1 FY18 STANDALONE RESULTS – RATIO ANALYSIS Ratio Analysis Standalone Head Q1 FY18, a Q1 FY17, a Expenses Direct Cost / Revenue 6.3% 9.0% R&D / Revenue 48.6% 33.4% S&M / Revenue 56.4% 32.4% G&A / Revenue 41.8% 28.4% Total Cost / Revenue 146.8% 94.1% Margin Gross Margin 93.7% 91.0% EBIDTA -53.1% -3.2

  20. Slide 20: Standalone Results – Balance Sheet

    Q1 FY18 STANDALONE RESULTS – BALANCE SHEET Rs Million Particulars Jun-17 Jun-16 Particulars Jun-17 Jun-16 Non-Current Assets: Share Holders’ Funds: Property, plant and equipment 1,761.9 1,747.9 Equity share capital 701.9 700.3 Capital work-in-progress 133.0 94.2 Share application money pending Other

  21. Slide 21: Shareholding Structure

    SHAREHOLDING STRUCTURE Public, 19.45 Institutions, 7.84 % Shareholding – June 2017 Promoter & Promoter Group, 72.7 Source – BSE 21

  22. Slide 22: For Further Queries

    FOR FURTHER QUERIES Mr Rajesh Ghonasgi Vatsal Mehta / Nilesh Dalvi Quick Heal Technologies Limited Dickenson Seagull IR CFO IR Consultant Email ID: rajesh.ghonasgi@quickheal.co.in Email ID: vatsal.mehta@dickensonir.com nilesh.dalvi@dickensonir.com Contact No:+91 9712129581 / 9819289131 22

Quick Heal Technologies — Q1 FY18 Earnings Presentation on 6ix